vs

Side-by-side financial comparison of PBF Energy Inc. (PBF) and Stryker Corporation (SYK). Click either name above to swap in a different company.

Stryker Corporation is the larger business by last-quarter revenue ($7.2B vs $7.1B, roughly 1.0× PBF Energy Inc.). Stryker Corporation runs the higher net margin — 11.8% vs 1.1%, a 10.7% gap on every dollar of revenue. On growth, Stryker Corporation posted the faster year-over-year revenue change (11.4% vs -2.9%). Stryker Corporation produced more free cash flow last quarter ($1.9B vs $77.0M). Over the past eight quarters, Stryker Corporation's revenue compounded faster (16.9% CAGR vs -9.1%).

PBF Energy Inc. is a petroleum refining and logistics company that produces and sells transportation fuels, heating oils, lubricants, petrochemical feedstocks, and other petroleum products. The company owns and operated 6 refineries throughout the United States, located in Chalmette, Louisiana; Toledo, Ohio; Paulsboro, New Jersey; the Delaware City Refinery in Delaware City; Torrance, California; Martinez, California. PBF produces a range of products including gasoline, ultra-low-sulfur diese...

The Stryker is a family of eight-wheeled armored fighting vehicles derived from the Canadian LAV III, which in turn derived from the Swiss Mowag Piranha. Stryker vehicles are produced by General Dynamics Land Systems-Canada (GDLS-C) for the United States Army in a plant in London, Ontario. It has four-wheel drive (8×4) and can be switched to all-wheel drive (8×8).

PBF vs SYK — Head-to-Head

Bigger by revenue
SYK
SYK
1.0× larger
SYK
$7.2B
$7.1B
PBF
Growing faster (revenue YoY)
SYK
SYK
+14.3% gap
SYK
11.4%
-2.9%
PBF
Higher net margin
SYK
SYK
10.7% more per $
SYK
11.8%
1.1%
PBF
More free cash flow
SYK
SYK
$1.8B more FCF
SYK
$1.9B
$77.0M
PBF
Faster 2-yr revenue CAGR
SYK
SYK
Annualised
SYK
16.9%
-9.1%
PBF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBF
PBF
SYK
SYK
Revenue
$7.1B
$7.2B
Net Profit
$78.4M
$849.0M
Gross Margin
-1.8%
64.5%
Operating Margin
1.8%
25.2%
Net Margin
1.1%
11.8%
Revenue YoY
-2.9%
11.4%
Net Profit YoY
127.1%
55.5%
EPS (diluted)
$0.74
$2.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBF
PBF
SYK
SYK
Q4 25
$7.1B
$7.2B
Q3 25
$7.7B
$6.1B
Q2 25
$7.5B
$6.0B
Q1 25
$7.1B
$5.9B
Q4 24
$7.4B
$6.4B
Q3 24
$8.4B
$5.5B
Q2 24
$8.7B
$5.4B
Q1 24
$8.6B
$5.2B
Net Profit
PBF
PBF
SYK
SYK
Q4 25
$78.4M
$849.0M
Q3 25
$170.1M
$859.0M
Q2 25
$-5.2M
$884.0M
Q1 25
$-401.8M
$654.0M
Q4 24
$-289.3M
$546.0M
Q3 24
$-285.9M
$834.0M
Q2 24
$-65.2M
$825.0M
Q1 24
$106.6M
$788.0M
Gross Margin
PBF
PBF
SYK
SYK
Q4 25
-1.8%
64.5%
Q3 25
0.5%
63.6%
Q2 25
-0.8%
63.8%
Q1 25
-5.9%
63.8%
Q4 24
-4.2%
64.9%
Q3 24
-3.4%
64.0%
Q2 24
0.1%
63.0%
Q1 24
2.5%
63.6%
Operating Margin
PBF
PBF
SYK
SYK
Q4 25
1.8%
25.2%
Q3 25
3.7%
18.7%
Q2 25
0.6%
18.5%
Q1 25
-7.2%
14.3%
Q4 24
-5.2%
9.0%
Q3 24
-4.6%
19.7%
Q2 24
-0.9%
19.4%
Q1 24
1.7%
18.5%
Net Margin
PBF
PBF
SYK
SYK
Q4 25
1.1%
11.8%
Q3 25
2.2%
14.2%
Q2 25
-0.1%
14.7%
Q1 25
-5.7%
11.1%
Q4 24
-3.9%
8.5%
Q3 24
-3.4%
15.2%
Q2 24
-0.7%
15.2%
Q1 24
1.2%
15.0%
EPS (diluted)
PBF
PBF
SYK
SYK
Q4 25
$0.74
$2.20
Q3 25
$1.45
$2.22
Q2 25
$-0.05
$2.29
Q1 25
$-3.53
$1.69
Q4 24
$-2.41
$1.41
Q3 24
$-2.49
$2.16
Q2 24
$-0.56
$2.14
Q1 24
$0.86
$2.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBF
PBF
SYK
SYK
Cash + ST InvestmentsLiquidity on hand
$527.9M
$4.0B
Total DebtLower is stronger
Stockholders' EquityBook value
$5.3B
$22.4B
Total Assets
$13.0B
$47.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBF
PBF
SYK
SYK
Q4 25
$527.9M
$4.0B
Q3 25
$482.0M
$3.3B
Q2 25
$590.7M
$2.4B
Q1 25
$468.6M
$2.3B
Q4 24
$536.1M
$3.7B
Q3 24
$976.7M
$3.9B
Q2 24
$1.4B
$1.9B
Q1 24
$1.4B
$2.3B
Stockholders' Equity
PBF
PBF
SYK
SYK
Q4 25
$5.3B
$22.4B
Q3 25
$5.2B
$21.8B
Q2 25
$5.1B
$21.2B
Q1 25
$5.1B
$20.9B
Q4 24
$5.5B
$20.6B
Q3 24
$5.9B
$20.1B
Q2 24
$6.3B
$19.8B
Q1 24
$6.5B
$19.2B
Total Assets
PBF
PBF
SYK
SYK
Q4 25
$13.0B
$47.8B
Q3 25
$13.0B
$47.1B
Q2 25
$13.0B
$46.3B
Q1 25
$13.0B
$46.0B
Q4 24
$12.7B
$43.0B
Q3 24
$13.1B
$43.8B
Q2 24
$14.1B
$39.1B
Q1 24
$13.8B
$39.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBF
PBF
SYK
SYK
Operating Cash FlowLast quarter
$366.6M
$2.1B
Free Cash FlowOCF − Capex
$77.0M
$1.9B
FCF MarginFCF / Revenue
1.1%
26.1%
Capex IntensityCapex / Revenue
4.1%
3.7%
Cash ConversionOCF / Net Profit
4.68×
2.52×
TTM Free Cash FlowTrailing 4 quarters
$-783.2M
$4.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBF
PBF
SYK
SYK
Q4 25
$366.6M
$2.1B
Q3 25
$25.7M
$1.5B
Q2 25
$191.1M
$1.1B
Q1 25
$-661.4M
$250.0M
Q4 24
$-329.7M
$1.9B
Q3 24
$-68.0M
$1.5B
Q2 24
$425.3M
$633.0M
Q1 24
$15.8M
$204.0M
Free Cash Flow
PBF
PBF
SYK
SYK
Q4 25
$77.0M
$1.9B
Q3 25
$-122.8M
$1.4B
Q2 25
$35.0M
$928.0M
Q1 25
$-772.4M
$127.0M
Q4 24
$-425.7M
$1.7B
Q3 24
$-169.8M
$1.3B
Q2 24
$371.8M
$481.0M
Q1 24
$-123.8M
$37.0M
FCF Margin
PBF
PBF
SYK
SYK
Q4 25
1.1%
26.1%
Q3 25
-1.6%
22.3%
Q2 25
0.5%
15.4%
Q1 25
-10.9%
2.2%
Q4 24
-5.8%
25.9%
Q3 24
-2.0%
23.7%
Q2 24
4.3%
8.9%
Q1 24
-1.4%
0.7%
Capex Intensity
PBF
PBF
SYK
SYK
Q4 25
4.1%
3.7%
Q3 25
1.9%
3.1%
Q2 25
2.1%
3.0%
Q1 25
1.6%
2.1%
Q4 24
1.3%
4.1%
Q3 24
1.2%
3.1%
Q2 24
0.6%
2.8%
Q1 24
1.6%
3.2%
Cash Conversion
PBF
PBF
SYK
SYK
Q4 25
4.68×
2.52×
Q3 25
0.15×
1.79×
Q2 25
1.26×
Q1 25
0.38×
Q4 24
3.54×
Q3 24
1.77×
Q2 24
0.77×
Q1 24
0.15×
0.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBF
PBF

Gasoline And Distillate$6.4B89%
Asphaltand Residual Oil$283.6M4%
Other$149.4M2%
Chemicals$145.1M2%
Logistics Group$93.5M1%
Lubricants$81.9M1%

SYK
SYK

Medical$1.3B18%
Endoscopy$1.1B16%
Traumaand Extremities$1.1B15%
Instruments$925.0M13%
Knees$749.0M10%
Neuro Cranial$669.0M9%
Neurovascular$539.0M8%
Hips$499.0M7%
Other Orthopaedics$267.0M4%
Spine$8.0M0%

Related Comparisons